News
Filter
-
LifeArc announces seed fund investment in start-up GyreOx
-
LifeArc boosts investment in Cambridge University spin-out PolyProx Therapeutics to advance new class of cancer medicines
-
LifeArc and Scottish Government Chief Scientist Office launch new funding scheme to boost translational research in Scotland
-
LifeArc marks Rare Disease Day 2020 with a call for more translational research
-
Celebrating the International Day of Women and Girls in Science
-
LifeArc and Action Medical Research launch funding call for research into rare diseases in children
-
Meet the 2019–2020 LifeArc Knowledge Transfer Innovation Fellows
-
LifeArc appoints new Chief Investment Officer (CIO)
-
Celebrating the successes of UK translation – our 2019 annual reception
-
Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust
-
LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
-
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
